GLP-1 Drugs for Weight Loss and Diabetes What You Need to Know (And What the Ads Won't Tell You) If you've seen Ozempic ads on TV, heard about it from a friend, or talked to your doctor about it, you're not alone
Semaglutide was developed in 2012 by a Danish pharmaceutical company called Novo Nordisk in an attempt to design an analogue of GLP-1 with long life that is resistant to degradation
Loss of Potency Risk of Bacterial or Fungal Growth Chemical Degradation Reduced Efficacy Need for Replacement Potential Health Risks Cost Implications for Replacement Interactions and Side Effects Semaglutide, while effective for many, can come with some common side effects
Our session demonstrated that survey-level content is appropriate for preclinical students, but objectives must align with block goals, remain relevant to USMLE Step 1, and be tailored to students' educational stages
This is highly valuable for treating male hypogonadism, preserving fertility, and maintaining normal sperm production when a patient is undergoing hormone replacement therapy
